Life Science Company News

Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens

Read more ››
By: GlobenewsWire - 20 Jan 2022

Chimerix to Present at B. Riley Virtual Oncology Conference

Read more ››
By: GlobenewsWire - 20 Jan 2022

AVEO Oncology Presents Three Posters for Tivozanib/Immunotherapy Combinations at the 2022 ASCO GI Cancers Symposium

Read more ››
By: GlobenewsWire - 20 Jan 2022

BioVie Announces Treatment of First Patient in Phase 2 Clinical Trial of NE3107 for the Treatment of Parkinson’s Disease

Read more ››
By: GlobenewsWire - 20 Jan 2022

NGM Bio to Participate in Upcoming Investor Conferences

Read more ››
By: GlobenewsWire - 20 Jan 2022

Cue Biopharma to Host Business Update Call and Webcast for Ongoing CUE-101 Clinical Trials

Read more ››
By: GlobenewsWire - 20 Jan 2022

First Patient Dosed in IntelGenx’s Resumed ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

Read more ››
By: GlobenewsWire - 20 Jan 2022

Aeterna Zentaris to Present at the Virtual Investor 2022 Top Picks Conference

Read more ››
By: GlobenewsWire - 20 Jan 2022

Akoya Biosciences Appoints Marilee Moy as Chief People Officer

Read more ››
By: GlobenewsWire - 20 Jan 2022

Elpiscience Announces First Patient Dosed in US Phase I Clinical Trial of Anti-CD39 Monoclonal Antibody ES002 for Treatment of Advanced Solid Tumors

Read more ››
By: GlobenewsWire - 20 Jan 2022

Compass Therapeutics Announces US FDA Clearance of Investigational New Drug Application for a Phase 2 Study of CTX-009, a Bispecific Antibody That Simultaneously Targets Delta-like Ligand 4 (DLL4) and Vascular Endothelial Growth Factor A (VEGF-A)

Read more ››
By: GlobenewsWire - 20 Jan 2022

Dyadic Introduces Novel Method to Produce Synthetic Cannabinoids and Precursors Utilizing C1 Cell Line Production Platform and Patent Pending Process

Read more ››
By: GlobenewsWire - 20 Jan 2022

Healthcare Triangle, Inc. Releases Shareholder Update

Read more ››
By: GlobenewsWire - 20 Jan 2022

Vallon Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference

Read more ››
By: GlobenewsWire - 20 Jan 2022

Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for Combination of Elzovantinib and Aumolertinib in EGFR Mutant Met-Amplified Non-Small Cell Lung Cancer

Read more ››
By: GlobenewsWire - 20 Jan 2022

Revelation Biosciences Inc. Announces First Group of Patients Dosed in Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx-99 for the Prevention of H3N2 Influenza Infection

Read more ››
By: GlobenewsWire - 20 Jan 2022

Neovasc Announces Publication Supporting the Neovasc Reducer™ Device

Read more ››
By: GlobenewsWire - 20 Jan 2022

Ceapro Inc. to Present at the Virtual Investor 2022 Top Picks Conference

Read more ››
By: GlobenewsWire - 20 Jan 2022

Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea

Read more ››
By: GlobenewsWire - 20 Jan 2022

GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer

Read more ››
By: GlobenewsWire - 20 Jan 2022
Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate